Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP.
about
Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg ResponseImmunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.Intravenous immunoglobulin in the treatment of neurologic disorders.Immunoglobulins: current understanding and future directions.Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDPNeurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patientsDiagnostic insights into chronic-inflammatory demyelinating polyneuropathiesTrapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis
P2860
Q26801349-9CD11EC3-F32D-471E-865A-4A302C5815AFQ36993318-52AD845C-60EF-4670-9A71-EE4026EE834FQ37339743-AD602BA4-6E2D-43AE-BE80-B404E90BE4C5Q38495457-3C2FF7E4-033F-4C93-9F87-BFEF782830A4Q39067335-191CBB10-26ED-407C-8BC1-DB63E7941C3DQ42290388-EC1A7AF9-9E5C-477A-AAA7-D4A5264508EAQ47221782-81E12DA6-3E79-48D6-B494-BBBA30A857B1Q47564469-60BEDFA6-0A7F-4862-A930-FFA62E832888Q48172357-6DC9BEE9-682F-4873-AC37-72C3B1E300F2Q52806003-1E92349A-A536-4884-8E96-86C3A5EE41F3Q56960415-461620A0-A850-45E6-AC2C-81EB4A7F7B67Q57300562-10B9BD6F-4AB5-4F06-8A80-E2ADF170991AQ58805914-D065A0D3-C5BD-4F70-971A-CFCF6B80C1E7
P2860
Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Effective treatment with intra ...... esponse in patients with CIDP.
@en
Effective treatment with intra ...... esponse in patients with CIDP.
@nl
type
label
Effective treatment with intra ...... esponse in patients with CIDP.
@en
Effective treatment with intra ...... esponse in patients with CIDP.
@nl
prefLabel
Effective treatment with intra ...... esponse in patients with CIDP.
@en
Effective treatment with intra ...... esponse in patients with CIDP.
@nl
P2093
P356
P1476
Effective treatment with intra ...... esponse in patients with CIDP.
@en
P2093
Andreas Meisel
Christian Meisel
Hendrik Harms
Jos Goehler
Juliane Klehmet
Siegfried Kohler
P304
P356
10.1136/JNNP-2014-307708
P407
P577
2014-07-29T00:00:00Z